# Bristol-Myers Squibb Company (BMY) — Q3-2013 Earnings Results

**Report date:** 2013-10-23 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2013

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 1.55%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.46 | N/A | +5.02% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting the importance of their ongoing projects. They emphasized a commitment to maintaining operational efficiency.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value through our pipeline.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock fell 1.55% on the day, likely due to the lack of revenue data and forward guidance, leaving investors uncertain about future performance. The cautious tone from management may have also contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2013_